GMO Benchmark-Free Allocation packages the firm’s contrarian views and value-driven asset-class forecasts. The differentiated approach is consistently applied by a research-focused team, but it can face prolonged periods of underperformance.
GMO Benchmark-Free Allocation IV GBMBX
- NAV / 1-Day Return 26.13 / +0.04 %
- Total Assets 2.6 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.110%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Global Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 5.53%
- Turnover 19%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 11:45 PM GMT+0
Morningstar’s Analysis GBMBX
Will GBMBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 3.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
United States Treasury Notes 1.375% | 6.12 | 236.6 Mil | Government |
United States Treasury Notes | 5.10 | 197.1 Mil | Government |
FHLBA | 3.12 | 120.6 Mil | Government |
United States Treasury Notes 1.25% | 2.94 | 113.8 Mil | Government |
United States Treasury Notes | 2.61 | 100.9 Mil | Government |
United States Treasury Notes | 2.35 | 90.9 Mil | Government |
United States Treasury Notes | 1.53 | 59.3 Mil | Government |
United States Treasury Notes | 1.42 | 55.0 Mil | Government |
United States Treasury Notes | 1.29 | 49.7 Mil | Government |
Dummygmo Benchmark-Free Allocation Strategy | −19.98 | −773.0 Mil | — |